Subcutaneous rather than intravenous ustekinumab induction is associated with comparable circulating drug levels and early clinical response: A pilot study

Alimentary Pharmacology&Therapeutics, EarlyView.

Source: Alimentary Pharmacology and Therapeutics - June 19, 2018 Category: Drugs & Pharmacology Authors: C. R. Rowan , D. Keegan, K. Byrne, G. Cullen , H. E. Mulcahy , J. Sheridan , E. J. Ryan , A. de Vries , G. D'Haens , G. A. Doherty Source Type: research